Skip to content

Carrier

Humana

Humana Inc. · Drug benefit: Humana's own pharmacy operation (Humana Clinical Pharmacy Review, CenterWell Pharmacy) · 6 documents cited · Read October 2026

Its Medicare drug plans don't cover GLP-1s for weight loss alone; the $50 Bridge runs beside them through CMS, not Humana.

American GLP, Publisher · Who writes this site

Humana is mostly a Medicare company now, so its GLP-1 documents are Medicare documents. The first thing they say is the Medicare rule: a standard Part D plan doesn't cover a GLP-1 only for weight loss.

The second thing is the exception that isn't Humana's. From July 1, 2026 the Medicare GLP-1 Bridge lets eligible Part D members get Foundayo, Wegovy or the Zepbound KwikPen for a $50 copay, and Humana's own page says the prior authorization goes to a CMS central processor, outside the Part D benefit.

Humana completed its exit from employer-group commercial medical coverage during 2025, according to its 2025 annual report. That exit included fully insured, self-funded and federal employee medical plans. It was separate from Humana's Medicare business.

Does a Humana Part D plan cover Wegovy or Zepbound for weight loss?

Not as part of the plan. Humana says so in plain words, and its 2026 prior-authorization criteria for Ozempic, Mounjaro, Rybelsus and Trulicity each list weight loss as an exclusion. Pharmacies have to enter a diagnosis code for a medically accepted use when they fill a GLP-1.

We also searched five of Humana's 2026 Part D documents — one Medicare Advantage drug guide and its criteria, three standalone drug-plan guides and their basic criteria — for Wegovy, Zepbound, Saxenda and Foundayo, and found none of them. That's our reading of those five documents, not a statement Humana makes.

How does the $50 Bridge work with a Humana plan?

You have to be enrolled in Part D, but the Bridge runs outside the Part D payment flow. Your doctor sends the prior authorization and the prescription to a CMS central processor. It runs through December 31, 2027.

Every claim above, with the document behind it

These are the policies we opened and the month we opened them. Each one carries its own policy number and effective date on its face, and those are printed here as the document shows them.

Read September 2026

"Standard Medicare Part D prescription drug plans don't cover GLP-1 medications only for weight loss."

Humana, "Does Medicare cover GLP-1 weight loss drugs?", effective June 2026 · source

"Starting July 1, 2026, the Medicare GLP-1 Bridge program will give eligible Part D plan members access to Foundayo®, Wegovy® (injection or tablet), or Zepbound® (KwikPen®) weight loss medications for a $50 copayment for each 30-day supply."

Humana, "Does Medicare cover GLP-1 weight loss drugs?", effective June 2026 · source

"First, your doctor must submit a prior authorization request and the prescription to a Centers for Medicare & Medicaid Services (CMS) central processor." The page adds: "You must be enrolled in Part D to participate; however, it will operate outside of the Part D benefit payment flow."

Humana, "Does Medicare cover GLP-1 weight loss drugs?", effective June 2026 · source

The prior-authorization criteria for Ozempic, Mounjaro, Rybelsus and Trulicity each carry the exclusion "The member is using for weight loss."

Humana, 2026 Super National 5 MAPD (Formulary ID 26408) Prior Authorization Criteria, effective September 2026 · source

"Pharmacies must enter diagnosis code for a medically accepted indication when processing a claim for a GLP-1 receptor agonist."

Humana, Commonly prescribed drugs Humana will cover in 2026 (Super National-5 MAPD) · source

"You may ask for an appeal within 65 days of the date of our Notice of Denial of Medicare Prescription Drug Coverage."

Humana, Request for Redetermination of Medicare Prescription Drug Denial · source

February 23, 2023: Humana "will be exiting the Employer Group Commercial Medical Products business, which includes all fully insured, self-funded and Federal Employee Health Benefit medical plans, as well as associated wellness and rewards programs." It added: "The exit from this line of business will be phased over the next 18 to 24 months."

Humana, "Humana to Exit Employer Group Commercial Medical Products Business", effective February 2023 · source

Read October 2026

Humana's 2025 annual report says it completed the employer-group commercial medical exit during 2025, including fully insured, self-funded and federal employee medical plans. Other Humana health plan offerings were not materially affected.

Humana, 2025 Annual Report, Employer Group Commercial Medical Products Business Exit (page 41) · source

What these documents cannot tell you

Everything above is what Humana publishes for Medicare. It says nothing about a Humana employer plan, and it covers only the formularies we opened.

  • We read one Medicare Advantage formulary and three standalone drug-plan guides. Other Humana formularies, special-needs plans and group Medicare plans weren't checked.
  • The Bridge is a CMS program. Humana's plan doesn't decide it, and its approval runs through a CMS processor.
  • The annual report resolves the timing of Humana's commercial employer-plan exit. It does not establish drug coverage for a group Medicare plan; that plan's own Evidence of Coverage still governs.
  • None of this is legal or medical advice. Your plan's Evidence of Coverage and your notice govern your case.

Where this comes from

Read September 2026 unless marked.

  1. Humana, "Does Medicare cover GLP-1 weight loss drugs?", effective June 2026 — Open the document
  2. Humana, 2026 Super National 5 MAPD (Formulary ID 26408) Prior Authorization Criteria, effective September 2026 — Open the document
  3. Humana, Commonly prescribed drugs Humana will cover in 2026 (Super National-5 MAPD) — Open the document
  4. Humana, Request for Redetermination of Medicare Prescription Drug Denial — Open the document
  5. Humana, "Humana to Exit Employer Group Commercial Medical Products Business", effective February 2023 — Open the document
  6. Humana, 2025 Annual Report, Employer Group Commercial Medical Products Business Exit (page 41) — Open the document (read October 2026)

Where to go next

American GLP is not a law firm, an insurer, a government office or a clinician, and nothing here is legal or medical advice. This page describes what Humana publishes. It is not affiliated with Humana Inc., and your own plan documents and your own notice govern your case. Policies carry effective dates and change — read the sources before you act.